Meanwhile, cannabis extractions company Adastra announced it’s now legally allowed to both produce and distribute psilocybin and cocaine. In a statement to VICE News, Health Canada said Adastra is licensed to produce the drugs for scientific and medical purposes but cannot sell products to the general public. “They are only permitted for sale to other licence holders who have cocaine listed on their licence, pharmacists, practitioners, hospitals, or the holder of a section 56(1) exemption for research purposes,” the agency said.
Both companies claim they received amendments under Health Canada’s Dealer’s Licenses, which grant manufacturers, doctors, and researchers exemptions to the Controlled Drugs and Substances Act, allowing them to legally possess and make banned drugs. In a news conference, Eby said the licenses were granted without consultation from the province. “It is not part of our provincial plan,” he said, noting that he would be following up with Health Canada about the announcements. Adastra said it’s license allows it to “interact with up to 250 grams of cocaine and to import coca leaves to manufacture and synthesize the substance.”